Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Explore this study’s insights into benzodiazepine prescriptions in emergency departments and understand their implications for patient care.
Emergency Medicine October 18th 2023
Explore the potential of rapid tapering in benzodiazepine detoxification through a compelling case study, offering new perspectives on treatment protocols for patients with concurrent opioid dependence.
Psychiatry October 3rd 2023
MDLinx
Discover how researchers have overcome a significant chemical hurdle in methylphenidate, potentially paving the way for more effective treatments for cocaine addiction.
Psychiatry September 12th 2023
Addiction Professional
The alarming findings on nitazenes’ impact on cardiac arrest rates and naloxone dosage requirements demand your attention; further details could change how we approach opioid overdose treatments.
Emergency Medicine September 6th 2023
SIVAD Diagnostic Medical Group’s novel drug testing strips, HarmGuard FX, are making strides in harm reduction, beginning in Delaware. These strips, a part of the wider Harm Stopper Program, signal a potential turning point in the battle against the national opioid crisis.
Psychiatry July 11th 2023
Semaglutide, a familiar medication for obesity and type 2 diabetes, might pave a new path in managing alcohol dependence. Unearth the potential of this medication, which could reshape our understanding of alcohol dependence treatment.
Endocrinology, Diabetes, Metabolism June 21st 2023